Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 205 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR EMA Recommends Extending the Indications for Dostarlimab October 17, 2023 Foodie Friday: Winter Warm-Up White Bean Soup February 11, 2022 Clinical Trials in Genitourinary Cancers: TALAPRO-2, KEYNOTE-905, and COSMIC-313 July 9, 2020 The Switch of Breast Tumours to HER2-Low Status in Recurrence Might... May 8, 2021 Load more HOT NEWS New analysis estimates over 21 million UK adults will be obese... Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy... No Survival Advantage from Radical Hysterectomy in Patients with Cervical Cancer... Mom Goes From Worried To Mortified After Finding Dark Brown Spot...
